Your browser doesn't support javascript.
loading
In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.
Ji, Peng; Gong, Yue; Jin, Ming-Liang; Wu, Huai-Liang; Guo, Lin-Wei; Pei, Yu-Chen; Chai, Wen-Jun; Jiang, Yi-Zhou; Liu, Yin; Ma, Xiao-Yan; Di, Gen-Hong; Hu, Xin; Shao, Zhi-Ming.
Affiliation
  • Ji P; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Gong Y; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Jin ML; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Wu HL; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Guo LW; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Pei YC; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Chai WJ; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Jiang YZ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Liu Y; Precision Cancer Medical Center, Fudan University Shanghai Cancer Center, Shanghai 201315, China.
  • Ma XY; Laboratory Animal Center, Fudan University Shanghai Cancer Center, Shanghai 201315, China.
  • Di GH; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Hu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Shao ZM; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Sci Adv ; 8(26): eabl8247, 2022 07.
Article in En | MEDLINE | ID: mdl-35767614

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Sci Adv Year: 2022 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Sci Adv Year: 2022 Type: Article Affiliation country: China